Drug Delivery Systems

J&J’s Inlexzo Bladder Cancer Therapy Wins ‘Practice-Changing’ FDA Approval

4 hours ago talkbio0Tagged Approved, BCG-Unresponsive, Carcinoma, Drug Delivery Systems, gemcitabine intravesical system, in situ, Inlexzo, Johnson & Johnson, Malignant neoplasm of urinary bladder, New, Non-Muscle Invasive Bladder Neoplasms, SunRISe-1 trial, United States Food and Drug Administration

Inlexzo; FDA approval; bladder cancer; Johnson & Johnson; gemcitabine intravesical system; BCG-unresponsive; non-muscle invasive bladder cancer; SunRISe-1 trial; novel drug delivery; carcinoma in situ

Advancing Aseptic Manufacturing: GRAM’s Vision for the Future of Sterile Drug Production

6 months ago talkbio0Tagged Advanced phase, Annex 1, aseptic manufacturing, Automation, capabilities, Drug Delivery Systems, fill-finish, Flexible, isolator technology, Patient-centric solutions, Regulatory Compliance, Robotics, strategic partnerships

Aseptic manufacturing , Isolator technology, Automation and robotics, Flexible fill-finish capabilities, Advanced drug delivery systems, Regulatory compliance (Annex 1), Strategic partnerships, Patient-centric solutions